Searching for the Causal Variants of the Association Between Hypertriglyceridemia and the Genome-Wide Association Studies-Derived Signals? Take a Look in the Native American Populations.

Carlos A Aguilar-Salinas, Magdalena Del Rocío Sevilla González, María Teresa Tusie-Luna
{"title":"Searching for the Causal Variants of the Association Between Hypertriglyceridemia and the Genome-Wide Association Studies-Derived Signals? Take a Look in the Native American Populations.","authors":"Carlos A Aguilar-Salinas, Magdalena Del Rocío Sevilla González, María Teresa Tusie-Luna","doi":"10.1161/CIRCGENETICS.117.002010","DOIUrl":null,"url":null,"abstract":"Genome-wide association studies (GWAS) have made possible the identification of >175 loci that affect plasma lipid levels. Its results have been crucial to identify roles of new players in lipid metabolism (ie, apolipoprotein A5) or even to postulate potential treatment targets (ie, apolipoprotein C-III). However, a large proportion of the GWAS results has not been translated in clinically useful information because a large proportion of responsible single nucleotide polymorphisms (SNPs) are located either in noncoding regions or in genes without an obvious participation in any metabolic pathway.1 This is the case of the association between rs964184 and plasma triglycerides concentrations. This highly significant association has been a constant finding in the GWAS reports, regardless the sample size or the study sample composition.2 The frequency of the risk allele (G) varies between populations from 12% in whites to 27% in Mexicans. Also, it is common in Japanese (31%) and in Native American communities located in Central Mexico (≈50%). This SNP is nearby the 3′ untranslated region of the zinc finger gene ( ZPR1 ) and close to APOA5 . However, the identification of the functional variant that explains the association has not been possible.\n\nSee Article by Hsueh et al \n\nThe study of ethnic groups not included in the discovery cohorts, some methodological approaches (ie, admixture mapping or inception by descent [IBD] mapping), and deep genotyping are among the potential approaches to identify the variants responsible for a GWAS signal.3 The study of the Native American populations is an option because this group has not included in the majority of the lipids-related GWAS. The greater susceptibility of the populations derived from the Native American founding groups for having hypertriglyceridemia is well documented.4 These groups include the Amerindian communities living in Canada and the United States, mestizos living in the …","PeriodicalId":10277,"journal":{"name":"Circulation: Cardiovascular Genetics","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1161/CIRCGENETICS.117.002010","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Cardiovascular Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/CIRCGENETICS.117.002010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Genome-wide association studies (GWAS) have made possible the identification of >175 loci that affect plasma lipid levels. Its results have been crucial to identify roles of new players in lipid metabolism (ie, apolipoprotein A5) or even to postulate potential treatment targets (ie, apolipoprotein C-III). However, a large proportion of the GWAS results has not been translated in clinically useful information because a large proportion of responsible single nucleotide polymorphisms (SNPs) are located either in noncoding regions or in genes without an obvious participation in any metabolic pathway.1 This is the case of the association between rs964184 and plasma triglycerides concentrations. This highly significant association has been a constant finding in the GWAS reports, regardless the sample size or the study sample composition.2 The frequency of the risk allele (G) varies between populations from 12% in whites to 27% in Mexicans. Also, it is common in Japanese (31%) and in Native American communities located in Central Mexico (≈50%). This SNP is nearby the 3′ untranslated region of the zinc finger gene ( ZPR1 ) and close to APOA5 . However, the identification of the functional variant that explains the association has not been possible. See Article by Hsueh et al The study of ethnic groups not included in the discovery cohorts, some methodological approaches (ie, admixture mapping or inception by descent [IBD] mapping), and deep genotyping are among the potential approaches to identify the variants responsible for a GWAS signal.3 The study of the Native American populations is an option because this group has not included in the majority of the lipids-related GWAS. The greater susceptibility of the populations derived from the Native American founding groups for having hypertriglyceridemia is well documented.4 These groups include the Amerindian communities living in Canada and the United States, mestizos living in the …
寻找高甘油三酯血症与全基因组关联研究衍生信号之间关联的因果变异?看看美洲原住民吧。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Circulation: Cardiovascular Genetics
Circulation: Cardiovascular Genetics CARDIAC & CARDIOVASCULAR SYSTEMS-GENETICS & HEREDITY
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊介绍: Circulation: Genomic and Precision Medicine considers all types of original research articles, including studies conducted in human subjects, laboratory animals, in vitro, and in silico. Articles may include investigations of: clinical genetics as applied to the diagnosis and management of monogenic or oligogenic cardiovascular disorders; the molecular basis of complex cardiovascular disorders, including genome-wide association studies, exome and genome sequencing-based association studies, coding variant association studies, genetic linkage studies, epigenomics, transcriptomics, proteomics, metabolomics, and metagenomics; integration of electronic health record data or patient-generated data with any of the aforementioned approaches, including phenome-wide association studies, or with environmental or lifestyle factors; pharmacogenomics; regulation of gene expression; gene therapy and therapeutic genomic editing; systems biology approaches to the diagnosis and management of cardiovascular disorders; novel methods to perform any of the aforementioned studies; and novel applications of precision medicine. Above all, we seek studies with relevance to human cardiovascular biology and disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信